medigraphic.com
ISSN 1561-3054 (Electronic)

2020, Number 3

<< Back Next >>

Rev Cubana Med Trop 2020; 72 (3)

Prophylactic therapeutic approach to reduce malaria morbidity among pregnant women

Marcos PMM, Fortes F, Machado MJF, Rojas RL

Language: Spanish
References: 20
Page: 1-13
PDF size: 276.61 Kb.


ABSTRACT

Introduction: Malaria infection during pregnancy is an important health problem in most tropical regions. This condition may have a negative incidence on pregnant women and fetuses.
Objective: Inquire into the effect of the intermittent preventive treatment with the malarial sulfadoxine / pyrimethamine in pregnant women.
Methods: A bibliographic review was conducted in the database Medline / PubMed and in relevant papers about the topic published in the last five years. The Guidelines for the Treatment of Malaria 2016-2017 of the World Health Organization were also used as reference.
Analysis and synthesis of results: Significant progress was not achieved in reducing the number of malaria patients in the period 2015-2017. However, anemia is reported as the cause of mortality during the course of malaria. New approaches and commitments are proposed to reduce malaria-related morbidity among pregnant women, namely effective treatment of malaria cases, use of insecticide-treated mosquito nets, and intermittent preventive treatment with the antimalarial sulfadoxine / pyrimethamine as of the second quarter of pregnancy. Indication of this treatment includes at least two doses of the malarial, with a separation of one month between the doses, regardless of whether the pregnant women have symptoms of the disease.
Conclusions: The intervention to prevent malaria during pregnancy is a first-priority aspect of the mother, child, reproductive health initiative. It also helps improve and broaden the coverage of measures for the control of this disease during pregnancy.


REFERENCES

  1. Organización Mundial de la Salud. Informe Mundial sobre el Paludismo. Informe de Grupo Científico de la OMS. Ginebra: OMS 2018, Serie de Informes Técnicos: 64.

  2. World Health Organization. World malaria report, 2017. Geneva. WHO; 2018. [acceso: 05/09/2019]. Disponible en: Disponible en: http://apps.who.int/iris/bitstream/ handle/10665/205559/WHO_HTM_GMP_2016.2_spa.pdf;jsessionid=DD8C013034924EE5 A4599CEE0C450615?sequence=1 2

  3. Requena P. Pregnancy and malaria exposure are associated with changes in the B cell pool and in plasma eotaxin levels. J Immunol. 2014;9(5):88-96.

  4. World Health Organization. Guidelines for the treatment of malaria. Geneva: WHO; 2017. [acceso: 19/09/2019]. Disponible en: Disponible en: http://apps.who.int/iris/bitstream/handle/10665/162441/9789241549127_eng.pdf?sequence=1 27

  5. Uneke CJ. Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa: I: Introduction to placental malaria. Yale J Biol Med. 2010;80:39-50.

  6. Prieto L, Cortes M, Cabrillo E, Gonzalez-Gonzalez A. Malaria and Pregnancy. Progresos de Obstetricia y Ginecología. 2015;48(1):23-4.

  7. Hammerich A, Campbell OM, Chandramohan D. Unstable malaria transmission and maternal mortality-experiences from Rwanda. Trop Med Int Health. 2015;7(7):573-6.

  8. Voittier G, Arsac M, Farnoux C, Kurdjian P, Baud O, Aujard Y. Congenital malaria in neonates: two case report and review of literature. Paediatrica. 2018;97:500-12.

  9. Wort U, Hastings I, Mutibingwa TK, Brabin B. The impact of endemic and epidemic malaria on the risk of stillbirth in two areas of Tanzania with different malaria transmission patterns. Malar J. 2016;5:89.

  10. McGregor IA. Epidemiology, malaria and pregnancy. Am J Trop Med Hyg. 2017;33(4):517-25.

  11. Diagne N, Rogler C, Gisse B, Trape JF. Incidence of clinical malaria in pregnant women exposed to intense perennial transmission. Trans R Soc Trop Med Hyg. 2017;91:166-70.

  12. Paya RC. Paludismo y gestación. Ginecol Obstet Clínica. 2014;5(4):204-10

  13. Menéndez C. Malaria during pregnancy: a priority area of malaria research and control. Parasitol Today. 2005;11(5):178-83.

  14. Shulman C, Marshall T, Dorman E, Bulmer J, Cutts F, Peshu N, et al. Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae. Trop Med Int Health. 2017;6(10):770-8.

  15. Rohrig G, Maier WA, Seitz HM. Grow-stimulating influence of human chorionic gonadatropin on Plasmodium falciparum in vitro. Zentralbl-Backteriol. 2017;289(1):89-99.

  16. Brabin B, Piper C. Anemia- and malaria attributable low birthweigth in two populations in Papua New Guinea. Ann Hum Biol. 2017;24:547-55.

  17. Menéndez C, D'Alessandro U, ter Kuile FO. Reducing the burden of malaria in pregnancy by preventive strategies. Lancet Infect Dis. 2017;7:126-35.

  18. World Health Organization. Guidelines for the treatment of malaria. Geneva: WHO; 2017. [acceso: 05/09/2019]. Disponible en: Disponible en: http://apps.who.int/iris/bitstream/handle/10665/162441/9789241549127_eng.pdf?sequence=1

  19. World Health Organization. Estrategia Técnica Mundial contra la Malaria 2016-2030. 2015. [acceso: 26/09/2019]. Disponible en: Disponible en: https://www.who.int/malaria/publications/atoz/9789241564991/es/

  20. Informe mundial sobre el paludismo 2017. Ginebra: Organización Mundial de la Salud, 2017. [acceso: 10/08/2019]. Disponible en: Disponible en: http://www.who.int/ malaria/publications/world_malaria_report_2017




2020     |     www.medigraphic.com